Skip to main content

Advertisement

SpringerLink
Log in

Importance of tumor size in soft tissue sarcomas: a proposal for a nomogram based on a score system to staging soft tissue sarcomas in the postoperative setting

  • Original Paper
  • Published:
Medical Oncology Aims and scope Submit manuscript

Abstract

In order to adequately stage patients with extremity soft tissue sarcomas (ESTS), it is mandatory to include all adverse prognostic factors and create an integral staging system. We were able to evaluate a nomogram based on a score (STSSS), to improve ESTS staging. We retrospectively evaluated 596 patients with ESTS in stages I–III, of the American Joint Committee on Cancer (AJCC), who had a complete resection. We analyzed the influence of clinicopathological factors on metastasis, recurrence, and disease-specific survival. The STSSS was based on histologic grade (HG), profundity, tumor size (TS), and surgical margins; we also compared STSSS versus AJCC systems in their ability to stage ESTS. The mean TS was 11.8 cm, with 50 % >10 cm. Large TS and high HG were independent but adverse prognostic factors for metastasis. In addition, large TS, high grade, and R1 resection were independent adverse prognostic factors for decreased survival. There was a progressive decline in survival as TS increased, although AJCC staging did not correlate well between stages (IA vs. IB p = 0.233, IA vs. IIA p = 0.123, IA vs. IIB p = 0.075, IB vs. IIA p = 0.472, IB vs. IIB p = 0.211). STSSS showed differences between these categories for 5-year survival (I vs. II p = 0.003, II vs. III p = 0.002, III vs. IV p < 0.001). Surgical margins, HG, and TS are important determinants for metastases and survival. We also found a strong correlation between survival and prognosis with the use of STSSS in the immediate postoperative setting.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Lachenmayer A, Yang Q, Eisenberger CF, Boelke E, Poremba C, Heinecke A, Ohmann C, Knoefel WT, Peiper M. Superficial soft tissue sarcomas of the extremities and trunk. World J Surg. 2009;33:1641–9.

    Article  PubMed  Google Scholar 

  2. Devita VT, Rosenberg SASH. Cancer: principles and practice of oncology. 7th ed. Philadelphia: Lippincott; 2004.

    Google Scholar 

  3. Wasif N, Tamurian RM, Christensen S, Do L, Martinez SR, Chen SL, Canter RJ. Influence of specialty and clinical experience on treatment sequencing in the multimodal management of soft tissue extremity sarcoma. Ann Surg Oncol. 2012;19:504–10.

    Article  PubMed  Google Scholar 

  4. Rosenberg SA, Tepper J, Glatstein E, Costa J, Baker A, Brennan M, DeMoss EV, Seipp C, Sindelar WF, Sugarbaker P, Wesley R. The treatment of soft-tissue sarcomas of the extremities: prospective randomized evaluations of (1) limb-sparing surgery plus radiation therapy compared with amputation and (2) the role of adjuvant chemotherapy. Ann Surg. 1982;196:305–15.

    Article  CAS  PubMed  Google Scholar 

  5. Yang JC, Chang AE, Baker AR, Sindelar WF, Danforth DN, Topalian SL, DeLaney T, Glatstein E, Steinberg SM, Merino MJ, Rosenberg SA. Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity. J Clin Oncol. 1998;16:197–203.

    CAS  PubMed  Google Scholar 

  6. Singer S, Demetri GD, Baldini EH, Fletcher CD. Management of soft-tissue sarcomas: an overview and update. Lancet Oncol. 2000;1:75–85.

    Article  CAS  PubMed  Google Scholar 

  7. Alderman AK, Kim HM, Kotsis SV, Chung KC. Upper-extremity sarcomas in the United States: analysis of the surveillance, epidemiology, and end results database, 1973–1998. J Hand Surg Am. 2003;28:511–8.

    Article  PubMed  Google Scholar 

  8. Liu CY, Yen CC, Chen WM, Chen TH, Chen PC, Wu HT, Shiau CY, Wu YC, Liu CL. Tzeng CH:Soft tissue sarcoma of extremities: the prognostic significance of adequate surgical margins in primary operation and reoperation after recurrence. Ann Surg Oncol. 2010;17:2102–11.

    Article  PubMed  Google Scholar 

  9. Lahat G, Tuvin D, Wei C, Anaya DA, Bekele BN, Lazar AJ, Pisters PW, Lev D, Pollock RE. New perspectives for staging and prognosis in soft tissue sarcoma. Ann Surg Oncol. 2008;15:2739–48.

    Article  CAS  PubMed  Google Scholar 

  10. Billingsley KG, Lewis JJ, Leung DH, Casper ES, Woodruff JM, Brennan MF. Multifactorial analysis of the survival of patients with distant metastasis arising from primary extremity sarcoma. Cancer. 1999;85:389–95.

    Article  CAS  PubMed  Google Scholar 

  11. Trojani M, Contesso G, Coindre JM, Rouesse J, Bui NB, de Mascarel A, Goussot JF, David M, Bonichon F, Lagarde C. Soft-tissue sarcomas of adults; study of pathological prognostic variables and definition of a histopathological grading system. Int J Cancer. 1984;33:37–42.

    Article  CAS  PubMed  Google Scholar 

  12. Mariani L, Miceli R, Kattan MW, Brennan MF, Colecchia M, Fiore M, Casali PG, Gronchi A. Validation and adaptation of a nomogram for predicting the survival of patients with extremity soft tissue sarcoma using a three-grade system. Cancer. 2005;103:402–8.

    Article  PubMed  Google Scholar 

  13. Stojadinovic A, Leung DH, Hoos A, Jaques DP, Lewis JJ, Brennan MF. Analysis of the prognostic significance of microscopic margins in 2,084 localized primary adult soft tissue sarcomas. Ann Surg. 2002;235:424–34.

    Article  PubMed  Google Scholar 

  14. Gronchi A, Casali PG, Mariani L, Miceli R, Fiore M, Lo Vullo S, Bertulli R, Collini P, Lozza L, Olmi P, Rosai J. Status of surgical margins and prognosis in adult soft tissue sarcomas of the extremities: a series of patients treated at a single institution. J Clin Oncol. 2005;23:96–104.

    Article  CAS  PubMed  Google Scholar 

  15. Stojadinovic A, Leung DH, Allen P, Lewis JJ, Jaques DP, Brennan MF. Primary adult soft tissue sarcoma: time-dependent influence of prognostic variables. J Clin Oncol. 2002;20:4344–52.

    Article  PubMed  Google Scholar 

  16. Stoeckle E, Gardet H, Coindre JM, Kantor G, Bonichon F, Milbeo Y, Thomas L, Avril A, Bui BN. Prospective evaluation of quality of surgery in soft tissue sarcoma. Eur J Surg Oncol. 2006;32:1242–8.

    Article  CAS  PubMed  Google Scholar 

  17. Lehnhardt M, Hirche C, Daigeler A, Goertz O, Ring A, Hirsch T, Drucke D, Hauser J, Steinau HU. Soft tissue sarcoma of the upper extremities. Analysis of factors relevant for prognosis in 160 patients. Chirurg. 2012;83:143–52.

    Article  CAS  PubMed  Google Scholar 

  18. Peiper M, Zurakowski D, Izbicki JR, Knoefel WT. Malignant fibrous histiocytoma of the extremities and trunk: an institutional review. Surgery. 2004;135:59–66.

    Article  PubMed  Google Scholar 

  19. Biau DJ, Ferguson PC, Turcotte RE, Chung P, Isler MH, Riad S, Griffin AM, Catton CN, O’Sullivan B, Wunder JS. Adverse effect of older age on the recurrence of soft tissue sarcoma of the extremities and trunk. J Clin Oncol. 2011;29:4029–35.

    Article  PubMed  Google Scholar 

  20. Lahat G, Dhuka AR, Lahat S, Lazar AJ, Lewis VO, Lin PP, Feig B, Cormier JN, Hunt KK, Pisters PW, Pollock RE, Lev D. Complete soft tissue sarcoma resection is a viable treatment option for select elderly patients. Ann Surg Oncol. 2009;16:2579–86.

    Article  CAS  PubMed  Google Scholar 

  21. Al-Refaie WB, Habermann EB, Dudeja V, Vickers SM, Tuttle TM, Jensen EH, Virnig BA. Extremity soft tissue sarcoma care in the elderly: insights into the generalizability of NCI Cancer Trials. Ann Surg Oncol. 2010;17:1732–8.

    Article  PubMed  Google Scholar 

  22. Trovik CS, Bauer HC, Alvegard TA, Anderson H, Blomqvist C, Berlin O, Gustafson P, Saeter G, Walloe A. Surgical margins, local recurrence and metastasis in soft tissue sarcomas: 559 surgically-treated patients from the Scandinavian Sarcoma Group Register. Eur J Cancer. 2000;36:710–6.

    Article  CAS  PubMed  Google Scholar 

  23. Salo JC, Lewis JJ, Woodruff JM, Leung DH, Brennan MF. Malignant fibrous histiocytoma of the extremity. Cancer. 1999;85:1765–72.

    Article  CAS  PubMed  Google Scholar 

  24. Atalar H, Basarir K, Yildiz Y, Saglik Y. Prognostic factors in patients with malignant fibrous histiocytoma of the extremities. Acta Orthop Traumatol Turc. 2007;41:271–6.

    PubMed  Google Scholar 

  25. National Comprehensive Cancer Network guideline for soft tissue sarcoma V.1.2010 Available at: http://www.nccn.org/professionals/physician_gls/PDF/sarcoma.pdfwebcite.

  26. Schreiber D, Rineer J, Katsoulakis E, Sroufe RL, Lange CS, Nwokedi E, Schwartz D, Choi K, Rotman M: Impact of postoperative radiation on survival for high-grade soft tissue sarcoma of the extremities after limb sparing radical resection. Am J Clin Oncol 35:13–17.

  27. Grimer R, Judson I, Peake D, Seddon B: Guidelines for the Management of Soft Tissue Sarcomas. Sarcoma 2010, 506182.

  28. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2006. CA Cancer J Clin. 2006;56:106–30.

    Article  PubMed  Google Scholar 

  29. Balch CM, Buzaid AC, Atkins MB, et al. A new American joint Committee on Cancer staging system for cutaneous melanoma. Cancer. 2000;88:1484–91.

    Article  CAS  PubMed  Google Scholar 

  30. Russell WO, Cohen J, Enzinger F, et al. A clinical and pathological staging system for soft tissue sarcomas. Cancer. 1977;40:1562–70.

    Article  CAS  PubMed  Google Scholar 

  31. Fleming ID, Cooper JS, Henson DE. AJCC cancer staging manual. 5th ed. Philadelphia: Lippincott-Raven; 1997.

    Google Scholar 

  32. Greene FL, Page DL, Fleming ID. AJCC cancer staging manual. 6th ed. New York: Springer; 2002.

    Book  Google Scholar 

  33. Greene FL, Page DL, Fleming ID. AJCC cancer staging manual. 7th ed. New York: Springer; 2010.

    Google Scholar 

  34. Ramanathan RC, A’Hern R, Fisher C, et al. Modified staging system for extremity soft tissue sarcomas. Ann Surg Oncol. 1999;6:57–69.

    Article  CAS  PubMed  Google Scholar 

  35. Trojani M, Contesso G, Coindre JM, et al. Soft-tissue sarcomas of adults; study of pathological prognostic variables and definition of a histopathological grading system. Int J Cancer. 1984;33:37–42.

    Article  CAS  PubMed  Google Scholar 

  36. Costa J, Wesley RA, Glatstein E, et al. The grading of soft tissue sarcomas. Results of a clinicohistopathologic correlation in a series of 163 cases. Cancer. 1984;53:530–41.

    Article  CAS  PubMed  Google Scholar 

  37. Kattan MW, Leung DH, Brennan MF. Postoperative nomogram for 12-year sarcoma-specific death. J Clin Oncol. 2002;20:791–6.

    Article  PubMed  Google Scholar 

  38. Rubin BP, Fletcher CD, Inwards C, et al. Protocol for the examination of specimens from patients with soft tissue tumors of intermediate malignant potential, malignant soft tissue tumors, and benign/locally aggressive and malignant bone tumors. Arch Pathol Lab Med. 2006;130:1616–29.

    PubMed  Google Scholar 

  39. Gutierrez JC, Perez EA, Franceschi D, et al. Outcomes for soft-tissue sarcoma in 8249 cases from a large state cancer registry. J Surg Res. 2007;141:105–14.

    Article  PubMed  Google Scholar 

  40. Pisters PWT, Brennan MF. Sarcomas of soft tissue. In: Abeloff MAJ, Lichter A, et al., editors. Clinical oncology. New York: Churchill Livingstone; 1995. p. 1799–832.

    Google Scholar 

  41. ten Heuvel SE, Hoekstra HJ, van Ginkel RJ, et al. Clinicopathologic prognostic factors in myxoid liposarcoma: a retrospective study of 49 patients with long-term follow-up. Ann Surg Oncol. 2007;14:222–9.

    Article  PubMed  Google Scholar 

  42. Gronchi A, Casali PG, Mariani L, et al. Status of surgical margins and prognosis in adult soft tissue sarcomas of the extremities: a series of patients treated at a single institution. J Clin Oncol. 2005;23:96–104.

    Article  CAS  PubMed  Google Scholar 

  43. Zagars GK, Ballo MT, Pisters PW, et al. Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy: an analysis of 1225 patients. Cancer. 2003;97:2530–43.

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

We have no conflict of interest and none to disclose.

Author information

Authors and Affiliations

  1. Surgical Oncology, Instituto Nacional de Cancerología, Mexico City, Mexico

    Rosa Angélica Salcedo Hernández, David Cantú de León, Ángel Herrera-Gómez & Héctor Martínez-Said

  2. Anatomic Pathology, Hospital y Fundación Médica Sur, Puente de piedra 150, Toriello Guerra, CP. 14050, Mexico City, Mexico

    Leonardo Saúl Lino-Silva

  3. Anatomic Pathology, Instituto Nacional de Cancerología, Mexico City, Mexico

    Abelardo Meneses-García

Authors
  1. Rosa Angélica Salcedo Hernández
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Leonardo Saúl Lino-Silva
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. David Cantú de León
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ángel Herrera-Gómez
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Héctor Martínez-Said
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Abelardo Meneses-García
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Leonardo Saúl Lino-Silva.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Salcedo Hernández, R.A., Lino-Silva, L.S., de León, D.C. et al. Importance of tumor size in soft tissue sarcomas: a proposal for a nomogram based on a score system to staging soft tissue sarcomas in the postoperative setting. Med Oncol 31, 873 (2014). https://doi.org/10.1007/s12032-014-0873-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s12032-014-0873-z

Keywords

Search

Navigation